Similar Papers

Paper Title
Journal
Date
Author
National Blood Foundation 2021 Research and Development summit: Discovery, innovation, and challenges in advancing blood and biotherapies.
Jerry A Holmberg ... Brian Custer
Transfusion | VOL. 62
Jerry A Holmberg, et. al.Jerry A Holmberg ... Brian Custer
28 Sep 2022
A Phase 1 Study of NKX101, an Allogeneic CAR Natural Killer (NK) Cell Therapy, in Subjects with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-Risk Myelodysplastic Syndrome (MDS)
Carlos Bachier ... Sarah Nikiforow
Blood | VOL. 136
Carlos Bachier, et. al.Carlos Bachier ... Sarah Nikiforow
05 Nov 2020
An industry survey of implementation strategies for clinical supply chain management of cell and gene therapies
Lequina Myles ... Terry David Church
Cytotherapy | VOL. 24
Lequina Myles, et. al.Lequina Myles ... Terry David Church
06 Nov 2021
Future Therapeutic Approaches for Inflammatory Bowel Diseases
Scott E Plevy ... Stephan R Targan
Gastroenterology | VOL. 140
Scott E Plevy, et. al.Scott E Plevy ... Stephan R Targan
28 Apr 2011
View more papers

More From: Cell and Gene Therapy Insights

Paper Title
Journal
Date
Author
Enhancing CAR-T cell generation: optimizing non-viral engineering of resting T cells for improved cancer immunotherapy
Akshaya Chandrasekaran
Cell and Gene Therapy Insights | VOL. 10
Akshaya ChandrasekaranAkshaya Chandrasekaran
12 Sep 2024
-
-
Cell and Gene Therapy Insights | VOL. 10
--
03 Sep 2024
iPSC-based therapy dilemmas explored: overcoming hurdles for future success
Melissa Carpenter ... Lise Munsie
Cell and Gene Therapy Insights | VOL. 10
Melissa Carpenter, et. al.Melissa Carpenter ... Lise Munsie
03 Sep 2024
It’s a match: cell line engineering for AAV manufacturing expands the options for therapeutic programs
Dovile Woods
Cell and Gene Therapy Insights | VOL. 10
Dovile WoodsDovile Woods
27 Aug 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.